Dare Bioscience Files Notice of Qualification
Ticker: DARE · Form: QUALIF · Filed: 2026-04-02T00:15:02-04:00
Sentiment: neutral
Topics: regulation-a, qualification, pharmaceuticals
TL;DR
Dare Bioscience qualified for an offering on 4/1/26. Bullish.
AI Summary
Dare Bioscience, Inc. filed a Notice of Qualification (Form QUALIF) on April 1, 2026, under Regulation A. The filing indicates the company's qualification for a specific offering, with its principal business in Pharmaceutical Preparations.
Why It Matters
This filing signifies Dare Bioscience's official qualification for a securities offering, potentially enabling them to raise capital for their pharmaceutical development activities.
Risk Assessment
Risk Level: medium — Regulation A offerings can be complex and carry inherent risks related to capital raising and market reception.
Key Numbers
- 2026-04-01 — Qualification Date (Date of qualification for the offering)
- 024-12688 — File Number (Associated with the Regulation A filing)
Key Players & Entities
- Dare Bioscience, Inc. (company) — Filer
- 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 (address) — Mailing and Business Address
- 2834 (sic_code) — Pharmaceutical Preparations
FAQ
What type of securities offering is this qualification for?
The filing is a Notice of Qualification under Regulation A, indicating qualification for a specific securities offering.
When was Dare Bioscience, Inc. qualified?
Dare Bioscience, Inc. was qualified on April 1, 2026.
What is the primary business of Dare Bioscience, Inc. according to the filing?
The filing lists the SIC code as 2834, which corresponds to Pharmaceutical Preparations.
What is the CIK number for Dare Bioscience, Inc.?
The CIK number for Dare Bioscience, Inc. is 0001401914.
Where is Dare Bioscience, Inc. located?
The company's mailing and business address is 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122.
From the Filing
EDGAR Filing Documents for 9999999994-26-000077 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form QUALIF - Notice of Qualification [Regulation A]: SEC Accession No. 9999999994-26-000077 Filing Date 2026-04-01 Accepted 2026-04-02 00:15:02 Documents 1 Qualification Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 primary_doc.html QUALIF 1 primary_doc.xml QUALIF 594 Complete submission text file 9999999994-26-000077.txt 1946 Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655 Dare Bioscience, Inc. (Filer) CIK : 0001401914 (see all company filings) EIN. : 204139823 | State of Incorp.: DE | Fiscal Year End: 1231 Type: QUALIF | Act: 33 | File No.: 024-12688 | Film No.: 26830438 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)